The Mission Report

MissionIR Market Pulse Clients

Atossa Genetics (ATOS)

Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography.

View Quote

CRAiLAR Technologies (CRLRF)

CRAiLAR Technologies is a provider of environmentally sustainable natural fiber – including flax, hemp and other bast fibers – used in textile, industrial, energy, medical and composite material applications. The company produces these fibers using a fraction of the water and chemical inputs needed for other natural fibers.

View Quote

Fission Energy Corp. (FIS)

Fission Energy Corp. is a uranium exploration and development company specializing in the strategic acquisition, exploration and development of uranium properties. The company has projects in Saskatchewan’s Athabasca Basin, Quebec, the Hornby Basin of Nunavut, Namibia, and the Macusani District of Peru.

View Quote


Roth Conference

25th Annual
ROTH Conference
March 17-20, 2013 - Ritz-Carlton, Laguna Niguel

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year's annual ROTH conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12. Bringing together executives from more than 400 growth companies, the 25th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit

Presenting Companies: A-E F-J K-O P-T U-Z


8x8, Inc. (EGHT)

8x8, Inc. (NASDAQ: EGHT) is a provider of innovative cloud communications and computing solutions. The company enables business conversations for more than 30,000 small and medium-sized businesses through cloud communications services, including VoIP business phone service, unified communications, call center and video conferencing solutions. 8x8 was recognized in the “Leaders” quadrant of Gartner’s 2012 Magic Quadrant for Unified Communications as a Service and was also named “No. 1 Provider of Hosted IP Telephony” by Frost & Sullivan. For more information, visit the company’s Web site:

A.T. Cross Company (ATX)

A.T. Cross Company (NASDAQ: ATX) is a designer and marketer of branded personal and business accessories, providing a variety of distinctive products for consumers desiring to enhance their images and facilitate their lifestyles. The company’s products include award-winning writing instruments, timepieces, nonprescription reading glasses, business accessories and Costa and Native Eyewear sunglasses, distributed in retail and corporate gift channels across the globe. For more information, visit the company’s Web site:

AbTech Holdings, Inc. (ABHD)

AbTech Holdings, Inc. (OTCBB: ABHD), through its subsidiary AbTech Industries, Inc., provides full-service environmental technology and engineering services to communities, industry and governments. The company’s innovative solutions address water pollution and contamination issues, and AbTech’s products are based on polymer technologies capable of removing hydrocarbons, sediment and other foreign elements in storm water runoff, flowing water and industrial process and wastewater. Among AbTech’s offerings is the pioneering new antimicrobial technology SmartSponge Plus. For more information, visit the company’s Web site:

Acacia Research Corp. (ACTG)

Acacia Research Corp. (NASDAQ: ACTG), through its subsidiaries, partners with inventors and patent owners to license patents to corporate users and share the revenue. With the expertise and resources to evaluate commercially valuable patents in any technology area or industry, the company’s subsidiaries control more than 250 patent portfolios, covering technologies used in a broad variety of industries. For more information, visit the company’s Web site:

ACADIA Pharmaceuticals, Inc. (ACAD)

ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) is a biopharmaceutical company with its focus on innovative treatments addressing unmet medical needs in neurological and related central nervous system disorders. Pimavanserin, which is in Phase III clinical development as a potential first-in-class treatment for Parkinson’s disease psychosis, leads the company’s pipeline of product candidates. All the company’s product candidates are small molecules emanating from discoveries made at ACADIA. For more information, visit the company’s Web site at

Acasti Pharma, Inc. (ACST)

Acasti Pharma, Inc. (NASDAQ: ACST), a subsidiary of Neptune Technologies & Bioresources, Inc., is engaged in the development of a portfolio of proprietary novel long-chain omega-3 phospholipids, which are the main component of cell membranes and are essential to all vital cell processes. The company is initially focusing on treatments for chronic cardiovascular and cardiometabolic conditions within the over-the-counter, medical food and prescription drug markets. For more information, visit the company’s Web site:

AcelRx Pharmaceuticals, Inc. (ACRX)

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is a specialty pharmaceutical company engaged in developing and commercializing innovative therapies for treating acute and breakthrough pain. The ARX-01 Sufentanil NanoTab PCA System, the company’s lead product candidate, is designed to solve problems associated with post-operative intravenous patient-controlled analgesia, which has been shown to harm patients after surgery due to side effects from morphine, the invasive IV delivery route and the complexity of infusion pumps. For more information, visit the company’s Web site:

Active Power, Inc. (ACPW)

Active Power, Inc. (NASDAQ: ACPW) is a designer and manufacturer of uninterruptible power supply (UPS) systems and modular infrastructure solutions that allow data centers and other mission-critical operations to remain “on” around the clock. Combined, the benefits of the power density, reliability and total cost of ownership of the company’s products are unmatched in the market, allowing the world’s top companies to achieve their most forward-thinking data center designs. For more information, visit the company’s Web site:

Actuate Corp. (BIRT)

Actuate Corp. (NASDAQ: BIRT) is the founder and co-leader of the BIRT open source project, which is used by more than 2 million developers worldwide and serves as the foundation for the ActuateOne platform. Actuate is headquartered in Silicon Valley and has more than 5,000 customers worldwide in a variety of business areas, including financial services, technology and the public sector. For more information, visit the company’s Web site:


ADA-ES, Inc. (NASDAQ: ADES) develops environmental technologies as well as provides equipment and specialty chemicals that enable coal-fueled power plants to meet emissions regulations by enhancing existing air pollution control equipment. The company's wholly owned subsidiaries include Advanced Emissions Solutions, Inc., ADA Intellectual Property, LLC and ADA Environmental Solutions, LLC. ADES also holds a 42.5% controlling interest in Clean Coal Solutions, LLC. For more information, visit the company's Web site at:

AdCare Health Systems, Inc. (ADK)

AdCare Health Systems, Inc. (NYSE AMEX: ADK) is a noted innovator in senior living and healthcare facility management. The company is engaged in developing, owning and managing assisted living facilities, nursing homes and retirement communities and also provides home healthcare services. Founded in 1988, AdCare aims to provide the highest quality in healthcare services for the elderly. For more information, visit the company’s Web site:

Adept Technology, Inc. (ADEP)

Adept Technology, Inc. (NASDAQ: ADEP) is one of the world’s leading providers of intelligent robots and autonomous mobile solutions and services, enabling customers to achieve precision, speed, quality and productivity in their assembly, handling, packaging, testing and logistical processes. Adept has a comprehensive portfolio of high-performance motion controllers, application development software, vision-guidance technology and high-reliability robot mechanisms with autonomous capabilities, providing specialized, cost-effective robotics systems and services to high-growth markets. For more information, visit the company’s Web site:

Aeterna Zentaris, Inc. (AEZS)

Aeterna Zentaris, Inc. (NASDAQ: AEZS) is an oncology and endocrinology drug development company that is presently investigating treatments for a variety of unmet medical needs. The company’s product pipeline consists of compounds at all stages of development – from drug discovery to marketed products. The company’s lead drug development candidates include Perifosine, AEZS-108 and AEZS-130. For more information, visit the company’s Web site:

Agenus, Inc. (AGEN)

Agenus, Inc. (NASDAQ: AGEN) is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including a number of product candidates that have advanced into late-stage clinical trials through corporate partners. For more information, visit the company’s Web site at

Alexza Pharmaceuticals, Inc. (ALXA)

Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) is a rapidly emerging pharmaceutical company engaged in researching, developing and commercializing novel, proprietary products for the acute treatment of central nervous system conditions such as agitation, acute repetitive seizures and insomnia. The company’s products are based on the Staccato system, which is a handheld inhaler designed to deliver a drug aerosol to the deep lung, providing rapid systemic delivery and therapeutic onset easily and conveniently for patients. For more information, visit the company’s Web site:

Align Technology, Inc. (ALGN)

Align Technology, Inc. (NASDAQ: ALGN) is the designer, manufacturer and marketer of Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign uses a series of clear, nearly invisible, removable appliances that correct malocclusion without the use of metal or ceramic brackets or wires – gently moving the teeth to a desired final position without the aesthetic and other limitations associated with braces. For more information, visit the company’s Web site:

Allana Potash Corp. (AAA)

Allana Potash Corp. (TSX: AAA) is a junior mining company focused on acquiring and developing potash assets on an international basis. Allana is presently developing the Dallol Potash Project – its previously explored flagship property located in Ethiopia. The company has secured financial support from two notable strategic investors: IFC and Liberty Metals and Mining. For more information, visit the company’s Web site:

Alter NRG Corp. (NRG)

Alter NRG Corp. (TSX: NRG) is a provider of alternative energy solutions to meet increasing world market demands for environmentally responsible and economically viable energy. The company’s chief objective, through its wholly owned subsidiary, is to further commercialize the Westinghouse Plasma Gasification Technology to provide renewable and clean energy solutions from a broad array of feedstocks. The company also aims to provide a broad range of energy outputs. For more information, visit the company’s Web site:

Alteva (ALTV)

Alteva (NYSE MKT: ALTV), formerly known as WVT Communications Group, is a global leader in providing cloud-based Unified Communications (UC) solutions for small, medium and enterprise businesses. The company was founded in 1902 and has continued from that time to adapt and stay at the forefront of technology, providing best-in-class hosted unified communications solutions by continuing to integrate new innovations from industry leaders. For more information, visit the company’s Web site:

Altra Holdings, Inc. (AIMC)

Altra Holdings, Inc. (NASDAQ: AIMC), through its wholly owned subsidiary Altra Industrial Motion, Inc., is a world leader in designing, producing and marketing a broad range of electromechanical power transmission and motion control products. With production facilities in nine countries, the company has strong brands covering more than 40 product lines. For more information, visit the company’s Web site:

Ambarella, Inc. (AMBA)

Ambarella, Inc. (NASDAQ: AMBA) is a leader in developing low-power, high-definition video compression and image processing solutions, with products that are used in a variety of HD cameras, including security IP-cameras, wearable sports cameras, digital still cameras and automotive video camera recorders. The company’s technology is additionally used in television broadcasting, with programs being transmitting throughout the world using Ambarella compression chips. For more information, visit the company’s Web site:

Amerigo Resources Ltd. (ARG)

Amerigo Resources Ltd. (TSX: ARG), through its wholly owned subsidiary Minera Valle Central (MVC), is a producer of copper and molybdenum concentrates from tailings from Codelco’s El Teniente mine – the largest underground copper mine in the world. MVC produced 51.7 million pounds of copper and 1.1 million pounds of molybdenum in 2012 and is treating all fresh tailings from El Teniente’s current production. For more information, visit the company’s Web site:

Antisense Therapeutics Ltd. (ATHJF)

Antisense Therapeutics Ltd. (OTC: ATHJF) is an Australian pharmaceutical drug discovery and development company focused on creating, developing and commercializing novel antisense therapeutics. The company’s strategy involves creating antisense drugs, in collaboration with technology and research partners, that address diseases for which there are large and/or poorly met markets; outsourcing preclinical and clinical testing of candidate drugs to expert contractors; and commercializing drugs with preclinical or clinical testing success through licensing deals or other partnerships with major pharmaceutical companies. For more information, visit the company’s Web site:

Applied Micro Circuits Corp. (AMCC)

Applied Micro Circuits Corp. (NASDAQ: AMCC), also known as AppliedMicro, is a worldwide leader in computing and connectivity solutions for next-generation cloud infrastructure and data centers. AppliedMicro is a leader in high-speed digital signal, Internet protocol, Ethernet packet and storage processing, offering patented innovations that provide highly integrated Systems-on-a-Chip (SoCs) for telecommunications, enterprise and consumer applications. Headquartered in Sunnyvale, Calif., the company delivers silicon solutions that significantly lower total ownership costs. For more information, visit the company’s Web site:

Apricus Biosciences, Inc. (APRI)

Apricus Biosciences, Inc. (NASDAQ: APRI) is a pharmaceutical company engaged in developing and marketing innovative treatments to help large patient populations across numerous high-demand therapeutic classes, including male and female sexual health. With three approved products, the company has additionally developed a strong pipeline of multiple late-stage product opportunities. Headquartered in San Diego, Calif., the company has commercial operations in both the U.S. and Europe. For more information, visit the company’s Web site at

ARI Network Services, Inc. (ARIS)

ARI Network Services, Inc. (OTC: ARIS) provides technology-enabled services for manufacturers and dealers in the outdoor power, power sports, marine, RV and appliance sectors. ARIS operates through three categories: electronic catalogs for publishing, viewing and interacting with technical reference information about equipment; lead management services, designed to help dealers; and Websites with e-commerce capabilities designed to generate sales through the sites and provide information to consumers in the dealers’ local areas. For more information, visit the company's Web site at

ARRIS Group, Inc. (ARRS)

ARRIS Group, Inc. (NASDAQ: ARRS) is a worldwide communications technology company focused on designing, engineering and supplying communications and IP technologies that support broadband services for residential and business customers across the globe. The company provides broadband operators with the tools and platforms they need to deliver and monitor advanced video, data and voice subscriber services such as whole home video across multiple screens, ultra-high-speed data, personalized advertising and carrier-grade telephony. For more information, visit the company’s Web site:

Astex Pharmaceuticals, Inc. (ASTX)

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. The company developed Dacogen (decitabine) for injection and receives significant royalties for its worldwide sales. For more information, visit the company’s Web site:

Atossa Genetics, Inc. (ATOS)

Atossa Genetics, Inc. (NASDAQ: ATOS), known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography. The company is also focused on research and development to enable the commercialization of treatments for pre-cancerous lesions. Atossa Genetics is based in Seattle, Wash. For more information, visit the company’s Web site:

Attunity Ltd. (ATTU)

Attunity Ltd. (NASDAQ: ATTU) is a leader in providing information availability software solutions that enable data access, sharing and distribution across heterogeneous enterprise platforms, organizations and the cloud. The company’s software solutions include data replication, change data capture (CDC), data connectivity, enterprise file replication (EFR), managed-file-transfer (MFT) and cloud data delivery. Attunity provides its software directly and indirectly through partners such as Microsoft, Oracle, IBM and HP. For more information, visit the company’s Web site:

Augme Technologies, Inc. (AUGT)

Augme Technologies, Inc. (OTCQB: AUGT) is a provider of strategic services and mobile marketing technology for leading consumer and healthcare brands. Selling its products through Hipcricket, Inc., its wholly owned subsidiary, Augme has a platform that has provided measurable successes in more than 250,000 campaigns for its clients and their agencies, including such American brand-name leaders as Macy’s, MillerCoors and Clear Channel. For more information, visit the company’s Web site:

Aurcana Corp. (AUNFF)

Aurcana Corp. (OTC: AUNFF) is an emerging senior silver producer currently possessing two operating mines in Mexico and Texas. The current installed capacity of the company’s Le Negra Mine in Mexico is 2,500 tpd, with a goal of reaching 3,000 tpd by the end of Q1 in 2013. The Shafter Mine in Texas commenced commissioning and mill testing on April 1, 2012, achieving commencement of commercial production on December 2012. For more information, visit the company’s Web site:

Avalon Rare Metals, Inc. (AVL)

Avalon Rare Metals, Inc. (NYSE MKT: AVL) is a mineral development company with its focus currently on rare metals deposits in Canada. The company’s 100-percent-owned flagship project, Nechalacho Deposit located in Thor Lake, NWT, is emerging as one of the world’s largest underdeveloped rare earth elements resources, with exceptional enrichment in the more valuable “heavy” rare earth elements. Nechalacho Deposit is one of the few potential sources of these critical elements located outside of China. For more information, visit the company’s Web site:

Avanir Pharmaceuticals, Inc. (AVNR)

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) is a biopharmaceutical company engaged in providing innovative medicines to patients with central nervous system disorders of high unmet medical need. The company has extensively invested in its pipeline, and Avanir is dedicated to advancing medicines that can significantly improve the lives of patients and their loved ones. For more information, visit the company’s Web site:

Axesstel, Inc. (AXST)

Axesstel, Inc. (OTCQB: AXST) is a leader in providing wireless voice, broadband access and connected home solutions for the global telecommunications market. The company’s best-in-class product portfolio includes phones, wire-line replacement terminals, security alert systems and 3G and 4G broadband gateway devices. Headquartered in San Diego, Calif., Axesstel has provided leading telecommunications operators and distributors across the globe with millions of devices. For more information, visit the company’s Web site:

AXION International Holdings, Inc. (AXIH)

AXION International Holdings, Inc. (OTCQB: AXIH) is a green technology company engaged in transforming waste plastics into structural building materials. The company uses 100% recycled consumer and industrial plastics to develop, market and sell recycled structural composite products through its ECOTRAX composite rail tie and STRUXURE building material lines. AXION delivers tested, proven and superior green solutions for infrastructure needs throughout the world, serving a variety of customers from the military to global engineering firms. For more information, visit the company’s Web site:

AXT, Inc. (AXTI)

AXT, Inc. (NASDAQ: AXTI) is a leading designer, developer, manufacturer and distributor of high-performance compound and single-element semiconductor substrates comprising gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge). The company’s manufacturing facilities are located in Beijing, China, with sales, administration and customer service functions taking place at its headquarters in Fremont, Calif. AXT’s substrate products are chiefly used in lighting display applications, wireless communications, fiber optic communications and solar cell. For more information, visit the company’s Web site:

Barfresh Food Group, Inc. (BRFH)

Barfresh Food Group, Inc. (OTCBB: BRFH) manufactures and distributes unique, ready-to-blend beverages. Utilizing a proprietary, patent-pending system, the company uses controlled, pre-packaged portions to deliver freshly made smoothies that are quick and cost-effective with no waste. The company’s ready-to-blend, all natural beverages are chiefly sold to restaurant chains in the fast food and fast casual dining sector. The company plans to target other segments of the food service industry, as well as the retail consumer market, in the future. For more information, visit the company’s Web site:

Barrett Business Services, Inc. (BBSI)

Barrett Business Services, Inc. (NASDAQ: BBSI) combines human resource outsourcing and professional management consulting in one innovative operational platform. BBSI is an industry leader in business management solutions, working with more than 3,000 clients in all facets of business across 23 states. BBSI’s integrated platform is based on the company’s expertise in payroll processing, employee benefits, workers’ compensation coverage, workplace safety programs and risk management. For more information, visit the company’s Web site:

Bauer Performance Sports Ltd. (BAU)

Bauer Performance Sports Ltd. (TSX: BAU) is a leader in developing and manufacturing ice hockey, roller hockey and lacrosse equipment and related apparel. With the most recognized and strongest brand in the ice hockey equipment sector, Bauer holds the top market share position in both ice hockey and roller hockey. The company’s products are marketed under the Bauer, Mission, Maverik, Cascade and Inaria brands and are distributed by sales representatives and independent distributors across the globe. For more information, visit the company’s Web site:

BioDelivery Sciences International, Inc. (BDSI)

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics – either independently or in partnerships with third parties. The company is currently focused on developing products to meet unmet patient needs in pain management and addiction, and its pain franchise presently consists of two products utilizing the patented BEMA technology: ONSOLIS and BEMA Buprenorphine, both in Phase 3 clinical development. For more information, visit the company’s Web site:

BioSpecifics Technologies Corp. (BSTC)

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company, has developed injectable collagenase (currently marketed as XIAFLEX in the U.S.) for 12 clinical indications. XIAFLEX is currently being marketed for the treatment of adult Dupuytren’s contracture patients with a palpable cord by Auxilium Pharmaceuticals in the U.S., and it is also approved for Dupuytren’s contracture in the European Union, Switzerland and Canada. XIAFLEX is additionally in clinical development to treat several other indications. For more information, visit the company’s Web site:

BioTime, Inc. (BTX)

BioTime, Inc. (NYSE MKT: BTX) is a biotechnology company with its focus on regenerative medicine and blood plasma volume expanders. The company’s broad platform of stem cell technologies is enhanced through subsidiaries that are focused on specific fields of application. The company’s lead product is Hextand, a blood plasma volume expander. BioTime is headquartered in Alameda, Calif. For more information, visit the company’s Web site:

Black Diamond, Inc. (BDE)

Black Diamond, Inc. (NASDAQ: BDE) is a world leader in designing, manufacturing and marketing innovative active outdoor performance products for climbing, mountaineering, backpacking, skiing, cycling and other outdoor recreation activities. Iconic in the outdoor industry, the company’s principal brands (Black Diamond, Gregory, POC and PIEPS) are intrinsically linked with the modern history of their associated sports. Black Diamond’s products are sold by leading specialty retailers in the United States and throughout the world. For more information, visit the company’s Web site:

Broadwind Energy, Inc. (BWEN)

Broadwind Energy, Inc. (NASDAQ: BWEN) is an innovator of integrated solutions for customers in the energy and infrastructure markets, applying decades of deep industrial expertise. The company provides solutions for the energy needs of the future – from gears and gearing systems for wind, oil and gas and mining applications to wind towers, comprehensive remanufacturing of gearboxes and blades, operations and maintenance services and industrial weldments. Broadwind Energy employs more than 800 team members in facilities throughout the U.S. For more information, visit the company’s Web site:

Calavo Growers, Inc. (CVGW)

Calavo Growers, Inc. (NASDAQ-GS: CVGW) is a world leader in the avocado industry, also procuring and marketing diversified fresh produce items ranging from tomatoes to tropical produce. Calavo manufactures and distributes guacamole and guacamole hummus, salsa and tortilla chips through its business segment under the Calavo brand name. Renaissance Food Group LLC, the company’s wholly owned subsidiary, creates, markets and distributes a variety of healthy, high-quality lifestyle products through fast-growing brands such as Garden Highway and Chef Essentials. For more information, visit the company’s Web site:

Caliber Imaging & Diagnostics, Inc. (LCDX)

Caliber Imaging & Diagnostics, Inc. (OTCBB: LCDX), formerly Lucid, Inc., provides a platform of products that offer increased productivity – from the doctor’s office to the surgeon’s operating room. The company’s integrated platform of tools and technology represent the future of skin cancer diagnosis, enabling accurate, quick and routine diagnoses. The company’s new class of products delivers precise accuracy, consistent reliability and online backup that, combined, provide life-saving early diagnosis. For more information, visit the company’s Web site:

Callidus Software, Inc. (CALD)

Callidus Software, Inc. (NASDAQ: CALD), conducting business as CallidusCloud, is a leader in providing cloud software. The company enables organizations to drive performance and productivity across their business with its hiring, learning, marketing and selling clouds. The combined power of the company’s clouds, its people and its partners drives growth, empowers the workforce and delivers real value, boosting performance for more than 1,700 leading organizations. For more information, visit the company’s Web site:

Capstone Turbine Corp. (CPST)

Capstone Turbine Corp. (NASDAQ: CPST) is a leading global producer of low-emission microturbine systems. Capstone was the first company to market microturbine energy products that were commercially viable, and the company has shipped more than 6,500 of its award-winning Capstone MicroTurbine systems to customers across the globe. Capstone is a member of the U.S. Environmental Protection Agency’s Combined Heat and Power Partnership, focused on improving the overall efficiency of the country’s energy infrastructure and also reducing pollutant emissions and greenhouse gases. For more information, visit the company’s Web site:

CAS Medical Systems, Inc. (CASM)

CAS Medical Systems, Inc. (NASDAQ: CASM) is a leader in developing and manufacturing medical devices for noninvasive patient monitoring. CASMED’s FORE-SIGHT Absolute Cerebral Oximeter provides a noninvasive, continuous measurement of absolute cerebral tissue oxygen saturation that is highly accurate. The company additionally provides a line of bedside patient vital signs monitoring products, proprietary noninvasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. For more information, visit the company’s Web site:

Cash America International, Inc. (CSH)

Cash America International, Inc. (NYSE: CSH) offers specialty financial services to consumers, operating 969 total locations as of Dec. 31, 2012. The company has 831 lending locations and 97 unconsolidated franchised check cashing centers in the U.S., as well as 47 pawn lending locations in central and southern Mexico. The company additionally offers consumer loans over the Internet. For more information, visit the company’s Web site:

Catalyst Pharmaceutical Partners, Inc. (CPRX)

Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) is a specialty pharmaceutical company engaged in developing and commercializing prescription drugs that target orphan neurological diseases and disorders. Firdapse, the company’s lead candidate, is currently undergoing testing in a global, multicenter phase III trial for treating LEMS. Catalyst is also developing a potentially safer and more potent vigabatrin analog for treating infantile spasms, epilepsy and other neurological conditions associated with reduced GABAergic signaling. For more information, visit the company’s Web site:

Cavium, Inc. (CAVM)

Cavium, Inc. (NASDAQ: CAVM) is a leader in providing semiconductor products for intelligent processing in networking, communications and the digital home. Cavium's portfolio is comprised of integrated, software-compatible processors that range in performance from 10 mbps to more than 100 gbps, enabling secure, intelligent functionality in enterprise, data-center, broadband/consumer and access & service provider equipment. The company’s processors are supported by ecosystem partners that provide operating systems, tool support, reference designs and other services. For more information, visit the company's Web site:

Cell Therapeutics, Inc. (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is a biopharmaceutical company engaged in developing and commercializing oncology products that make cancer more treatable. Using genomic information, the company has developed a personalized approach to cancer therapy with the goal of making standard-of-care treatment less toxic and more effective. CTI’s approach involves matching a drug candidate to a patient’s genetic profile to achieve the highest anti-tumor activity at the lowest dose with the fewest side effects. For more information, visit the company’s Web site:

Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is the first antibody-based combination immunotherapy company. Its drug candidate pipeline for treating cancer and other difficult-to-treat diseases is based on its antibody-focused Precision Targeted Immunotherapy (PTI) Platform, which is a complementary portfolio of monoclonal antibodies, antibody-targeted therapeutics and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, visit the company’s Web site:

Charles & Colvard Ltd. (CTHR)

Charles & Colvard Ltd. (NASDAQ GSM: CTHR) is the world’s sole manufacturer of moissanite, which is a unique, almost colorless gemstone that is distinguished from other gemstones and jewels by its exceptional fire, brilliance, luster, durability and rarity. Currently, the company’s Charles & Colvard Created Moissanite and Forever Brilliant gems are incorporated into fine jewelry that is sold through domestic and international retailers and other sales channels. For more information, visit the company’s Web site:

Chelsea Therapeutics International Ltd. (CHTP)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is a biopharmaceutical company engaged in acquiring and developing innovative products to treat a variety of human diseases, including disorders of the central nervous system. The company is presently pursuing FDA approval in the United States for Northera (droxidopa), which is a novel, late-stage, orally active therapeutic agent for treating symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure. For more information, visit the company’s Web site:

Chembio Diagnostics, Inc. (CEMI)

Chembio Diagnostics, Inc. (NASDAQ: CEMI) is a leading developer, manufacturer, licensor and marketer of point-of-care rapid diagnostic tests. The company’s two FDA PMA-approved, CLIA-waived rapid HIV tests are marketed in the United States by Alere, Inc., and the company markets its HIV STAT-PAK line of rapid HIV tests internationally. The Dual Path Platform technology, Chembio’s patented point-of-care test platform technology, is providing the company with a substantial pipeline of business opportunities. For more information, visit the company’s Web site:

China Ceramics Co. Ltd. (CCCL)

China Ceramics Co. Ltd. (NASDAQ: CCCL) is a leading Chinese manufacturer of ceramic tiles used for exterior siding, interior flooring and design in residential and commercial buildings. Sold under the Hengda, Hengdeli, TOERTO, WULIQIAO and Pottery Capital of Tang Dynasty brands, the company’s products are available in more than 2,000 styles, colors and size combinations and are distributed through an exclusive distribution network as well as directly to large property developers. For more information, visit the company’s Web site:

China Cord Blood Corporation (CO)

China Cord Blood Corporation (NYSE: CO) is China’s first and largest umbilical cord blood banking operator, in terms of geographical coverage, and is the only cord blood banking operator with multiple licenses. Current PRC government regulations only permit one cord blood banking operator to operate in each licensed region, and only seven licenses have been authorized to date. CCBC provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, visit the company’s Web site:

China Distance Education Holdings Limited (DL)

China Distance Education Holdings Limited (NYSE: DL) is a leader in providing online education in China that is focused on professional education. The company’s online courses are designed to aid professionals and other course participants in obtaining and maintaining the skills, licenses and certifications needed for pursuing accounting, law, healthcare, construction engineering and other industry-specific careers in China. CDEL additionally offers online test preparation courses, online foreign language courses and offline business startup training courses. For more information, visit the company’s Web site:

China Hydroelectric Corporation (CHC)

China Hydroelectric Corporation (NYSE: CHC) owns, develops and operates small hydroelectric power projects in the People’s Republic of China. The company generates and sells electrical power to local power grids through its geographically diverse portfolio of operating assets. China Hydroelectric currently owns 26 operating hydropower stations in China – of which 22 were acquired and four were constructed – with a total installed capacity of 548 megawatts. For more information, visit the company’s Web site:

China Ming Yang Wind Power Group Limited (MY)

China Ming Yang Wind Power Group Limited (NYSE: MY) is a leading and rapidly growing manufacturer of wind turbines in China. The company is focused on designing, manufacturing, selling and servicing megawatt-class wind turbines and produces advanced, highly adaptable wind turbines with high energy output – also providing customers with comprehensive post-sales services. Ming Yang co-develops wind turbines in cooperation with aerodyne Energiesysteme, a leading Germany-based wind turbine design firm. For more information, visit the company’s Web site:

China Mobile Games and Entertainment Ltd. (CMGE)

China Mobile Games and Entertainment Ltd. (NASDAQ: CMGE) is a leading Chinese mobile games company with integrated capabilities in developing, operating, selling and distributing mobile games in China. The company’s mobile handset design business complements its game development business, as it preinstalls its mobile games and game platforms on company-designed handsets – also increasing company knowledge of user habits and preferences in industry trends. For more information, visit the company’s Web site:

Chindex International, Inc. (CHDX)

Chindex International, Inc. (NASDAQ: CHDX) is an American healthcare company that provides healthcare services in China through United Family Healthcare, which is a network of private primary care hospitals and affiliated ambulatory clinic currently operating in Beijing, Shanghai, Tianjin and Guangzhou. Chindex also provides medical capital equipment and products through joint venture company Chindex Medical Ltd. The company’s aim is to continue its growth as a leading integrated healthcare provider in the Greater China region. For more information, visit the company’s Web site:

ChromaDex Corporation (CDXC)

ChromaDex Corporation (OTCBB: CDXC) is an innovative natural products company providing proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The company’s proprietary product pipeline includes the patented pTeroPure pterostilbene, which was named the 2010 North American Most Promising Ingredient of the Year by Frost & Sullivan. All of ChromaDex’s products are backed by extensive scientific research and intellectual property. For more information, visit the company’s Web site:

Cimatron Limited (CIMT)

Cimatron Limited (NASDAQ: CIMT) is a leader in providing integrated CAD/CAM software solutions for the tool-making and manufacturing industries. With three decades of experience and more than 40,000 installations throughout the world, Cimatron is dedicated to providing comprehensive, cost-effective solutions to streamline manufacturing cycles and ultimately shorten product delivery time. Included in the company’s product line are the CimatronE and GibbsCAM brands, along with software solutions for various tool-making and manufacturing applications. For more information, visit the company’s Web site:

Clean Diesel Technologies, Inc. (CDTI)

Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a vertically integrated worldwide manufacturer and distributor of emissions control systems and products. The company’s focus is on the heavy duty diesel and light duty vehicle markets. CDTi utilizes its proprietary patented Mixed Phase Catalyst (MPC) technology, ARIS selective catalytic reduction, Platinum Plus fuel-borne catalyst and other technologies to provide high-value sustainable solutions for reducing emissions, increasing energy efficiency and lowering the carbon intensity of on- and off-road engine applications. For more information, visit the company’s Web site:

Clean Energy Fuels Corp. (CLNE)

Clean Energy Fuels Corp. (NASDAQ: CLNE) is North America’s largest natural gas transportation fuel provider and a world leader in the expanding natural gas vehicle fueling market. The company has operations in compressed natural gas (CNG) and liquefied natural gas (LNG) vehicle fueling as well as constructing and operating natural gas fueling stations. The company’s wholly owned subsidiaries provide various applications, technology, equipment, operations, supplies, systems and services for the Clean Energy’s operations. For more information, visit the company’s Web site:

ClickSoftware Technologies Ltd. (CKSW)

ClickSoftware Technologies Ltd. (NASDAQ GS: CKSW) is a leader in providing automated mobile workforce management and service optimization solutions for the service industry. An innovator behind the “service chain optimization” and “real-time service enterprise” concepts, the company offers solutions that provide organizations with end-to-end visibility and control of their entire service management chain. ClickSoftware’s products are available via the cloud or on-premise. For more information, visit the company’s Web site:

Coastal Contacts, Inc. (COA)

Coastal Contacts, Inc. (NASDAQ: COA) is one of the largest online vision care product retailers on earth. Through its family of Web sites, Coastal empowers customers to easily browse, try on and buy eyewear, saving patrons time and money and also helping those in need through its “Change the View” project. Designing, producing and distributing the largest selection of glasses and contact lenses on the Internet, Coastal additionally offers a unique combination of designer eyewear and vision care accessories. For more information, visit the company’s Web site:

Cognex Corporation (CGNX)

Cognex Corporation (NASDAQ: CGNX) is a global leader in the machine vision industry, designing, developing, manufacturing and marketing a variety of products that incorporate sophisticated machine vision technology that gives them the ability to “see.” The company’s products include barcode readers, machine vision sensors and machine vision systems used in factories, warehouses and distribution centers worldwide to guide, gauge, inspect, identify and assure item quality during manufacturing and distribution. For more information, visit the company’s Web site:

Comstock Mining, Inc. (LODE)

Comstock Mining, Inc. (NYSE MKT: LODE) is a gold and silver mining company based in Nevada with extensive, contiguous property in the Comstock District. In 2003, Comstock Mining began acquiring properties in that district; since then, the company has consolidated a substantial portion of the Comstock District, commencing production in 2012. Comstock Mining continues to acquire properties in the Comstock District, expanding its footprint and creating opportunities for further exploration and mining. For more information, visit the company’s Web site:

Comverse, Inc. (CNSI)

Comverse, Inc. (NASDAQ: CNSI) is the leading global provider of telecom business enablement solutions, supporting service innovation and smart monetization through a robust portfolio of BSS, mobile Internet, value-added services, IP communications and professional services. The company serves more than 2 billion subscribers in over 125 countries covering more than 450 communication service providers. Offering solutions in a variety of delivery models, Comverse is ranked No. 55 in PwC’s Global 100 Software Leaders list. For more information, visit the company’s Web site:

Conceptus, Inc. (CPTS)

Conceptus, Inc. (NASDAQ: CPTS) is a world leader in developing and commercializing innovative device-based solutions for permanent birth control. The company developed, manufactures and markets the Essure Permanent Birth Control System, which remains the leading surgery-free permanent birth control method after 10 years on the market. Conceptus was founded in 1992 and continues its mission of pioneering the design, development and marketing of innovative solutions to advance women’s health. For more information, visit the company’s Web site:

Consolidated Water Co. Ltd. (CWCO)

Consolidated Water Co. Ltd. (NASDAQ: CWCO) is a developer and operator of seawater desalination plants and water distribution systems in parts of the world where naturally occurring supplies of drinkable water are scarce or nonexistent. The company’s water production and/or distribution facilities are located in the Cayman Islands, Belize, the British Virgin Islands and The Commonwealth of The Bahamas. The company’s headquarters are located in George Town, Grand Cayman, in the Cayman Islands. For more information, visit the company’s Web site:

Coronado Biosciences, Inc. (CNDO)

Coronado Biosciences, Inc. (NASDAQ: CNDO) is a biopharmaceutical company engaged in developing novel immunotherapy biologic agents for treating autoimmune diseases and cancer. The company’s two chief pharmaceutical product candidates in clinical development are: TSO (Trichuris suis ova or CNDO-201), which is a biologic for treating autoimmune diseases; and CNDO-109, which is a biologic that activates natural killer (NK) cells for treating acute myeloid leukemia, multiple myeloma and solid tumors. For more information, visit the company’s Web site:

CPI Aerostructures, Inc. (CVU)

CPI Aerostructures, Inc. (NYSE MKT: CVU) is a contract producer of structural aircraft parts. CPI Aero serves leading prime defense contractors, the U.S. Air Force and other branches of the armed forces, also acting as a subcontractor in the production of commercial aircraft parts for prime aircraft manufacturers. CPI Aero provides technical, engineering and program management services in conjunction with its assembly operations. The company is included in the Russell 2000 Index. For more information, visit the company’s Web site:

Craft Brew Alliance, Inc. (BREW)

Craft Brew Alliance, Inc. (NASDAQ: BREW) is an independent craft brewing company that was created with the 2008 merger of leading Pacific Northwest craft brewers Widmer Brothers Brewing and Redhook Ale Brewery. CBA was joined by Kona Brewing Company in 2010, and the company launched Omission beer in 2012, which is the first craft beer brand in the U.S. to focus solely on brewing great-tasting craft beers with traditional ingredients that are specially crafted to remove gluten. For more information, visit the company’s Web site:

CRAiLAR Technologies, Inc. (CRLRF)

CRAiLAR Technologies, Inc. (OTCBB: CRLRF) is a provider of cost-effective and environmentally sustainable natural fiber – including flax, hemp and other bast fibers – used in textile, industrial, energy, medical and composite material applications. The company produces these fibers using a fraction of the water and chemical inputs needed for other natural fibers. The company’s CRAiLAR Flax, supplied to companies like HanesBrands, Georgia-Pacific, Target Corp. and Levi Strauss & Co., is the newest natural fiber to hit the market in decades. For more information, visit the company’s Web site:

Crown Crafts, Inc. (CRWS)

Crown Crafts, Inc. (NASDAQ-CM: CRWS) is a designer, marketer and distributor of products for infant, toddler and juvenile consumers. The company’s products include crib and toddler bedding and blankets; nursery and bath accessories; reusable and disposable bibs and floor mats; burp cloths; room décor; and disposable placemats, toilet seat covers and changing mats. Hamco, Inc. in Louisiana and Crown Crafts Infant Products, Inc. in California are among the company’s operating subsidiaries. For more information, visit the company’s Web site:

Curis, Inc. (CRIS)

Curis, Inc. (NASDAQ: CRIS) is a drug development company seeking to develop and commercialize next-generation targeted small molecule drug candidates for the treatment of cancer. Erivedge, the first and only medicine approved by the FDA to treat advanced basal cell carcinoma, is being commercialized and developed by Roche and Genentech under a collaboration between Curis and Genentech. Curis is additionally leveraging its experience in targeting signaling pathways to develop proprietary targeted cancer programs. For more information, visit the company’s Web site:

Cutera, Inc. (CUTR)

Cutera, Inc. (NASDAQ: CUTR) is a global leader in providing laser and other energy-based aesthetic systems for practitioners throughout the world. For the past 15 years, Cutera has been engaged in the development of innovative, easy-to-use products that allow physicians and other qualified practitioners to provide safe and effective aesthetic treatments for their patients. For more information, visit the company’s Web site:

CyberOptics Corporation (CYBE)

CyberOptics Corporation (NASDAQ: CYBE) is a leader in providing sensors and inspection systems that offer process yield and throughput improvement solutions for the worldwide electronic assembly and semiconductor capital equipment markets. CyberOptics deploys its products on production lines that manufacture surface mount technology circuit boards and semiconductor process equipment. Improving productivity and product quality, the company’s sensors and inspection systems enable electronics manufacturers to strengthen their competitive positions in markets that are highly price sensitive. For more information, visit the company’s Web site:

Cytokinetics, Inc. (CYTK)

Cytokinetics, Inc. (NASDAQ: CYTK) is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule therapeutics that modulate muscle function to potentially treat serious diseases and medical conditions. The company has various drug candidates at different stages of clinical development, some in partnership with other companies, that are directed toward the cytoskeleton and have arisen from Cytokinetics’ muscle biology-focused research activities. For more information, visit the company’s Web site:

Cytori Therapeutics, Inc. (CYTX)

Cytori Therapeutics, Inc. (NASDAQ: CYTX) is engaged in the development of cell therapies that are based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease and the repairing of soft tissue defects. The company’s scientific data suggests that ADRCs improve blood flow; resultantly, Cytori believes these cells can be applied across multiple ischemic conditions. Through the company’s proprietary technologies and products, these therapies are made available to physicians and patients at the point-of-care. For more information, visit the company’s Web site:

CytRx Corporation (CYTR)

CytRx Corporation (NASDAQ: CYTR) is an oncology-focused biopharmaceutical research and development company. The company’s oncology pipeline includes two programs, aldoxorubicin and tamibarotene, that are currently in clinical development for cancer indications. The company has also completed its evaluation of a third drug candidate, bafetinib, in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia, and intends to seek a partner for further development. For more information, visit the company’s Web site:

D-BOX Technologies, Inc. (DBO)

D-BOX Technologies, Inc. (TSX: DBO) is a leader in innovative motion technology. The company’s pioneering motion systems are primarily used in the entertainment and industrial simulation industries. The patented D-BOX Motion Code utilizes motion effects that are specifically programmed for each visual content and then sent to a motion system that has been integrated into a platform, such as a seat or any other product. The resulting motion is realistically synchronized with the onscreen action. For more information, visit the company’s Web site:

DARA BioSciences, Inc. (DARA)

DARA BioSciences, Inc. (NASDAQ: DARA) is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA is part of an integrated national network with yearly sales of more than $1 billion in cancer therapeutics, and its distribution network consists of more than 45,000 retail pharmacies, mail order pharmacies and long-term care facilities. For more information, visit the company’s Web site:

Datawatch Corporation (DWCH)

Datawatch Corporation (NASDAQ-CM: DWCH) is a leading global provider of information optimization products and solutions that enable organizations to offer the greatest possible data variety in their big data and analytic applications. The company enables organizations to integrate structured, unstructured and semi-structured sources, such as reports, PDF files and EDI streams, into these applications, providing a 360-degree perspective of issues and opportunities existing within their businesses. For more information, visit the company’s Web site:

Dejour Energy, Inc. (DEJ)

Dejour Energy, Inc. (NYSE MKT: DEJ) is an independent oil and natural gas exploration and production company. The company operates projects in North America’s Piceance Basin and its environs (around 129,000 net acres) as well as the Peace River Arch regions (around 8,500 net acres). Consistently among early identifiers of premium energy assets, the company’s seasoned management team has repeatedly timed investments and transactions to realize their value for the best advantage of shareholders. For more information, visit the company’s Web site:

Delcath Systems, Inc. (DCTH)

Delcath Systems, Inc. (NASDAQ: DCTH) is an oncology-focused specialty pharmaceutical and medical device company. The Delcath Hepatic Delivery System, the company’s proprietary drug/device combination product, is designed to administer high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body – controlling the systemic exposure of those agents at the same time. Delcath’s initial focus is on treating primary and metastatic liver cancers. For more information, visit the company’s Web site:

DelMar Pharmaceuticals, Inc. (DMPI)

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) is focused on developing and commercializing proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. VAL-083, the company’s lead asset, is presently undergoing clinical trials in the U.S. to potentially treat refractory glioblastoma multiforme (GBM), which is the most common and aggressive form of brain cancer. VAL-083 is currently approved to treat chronic myelogenous leukemia (CML) and lung cancer in China. For more information, visit the company’s Web site:

Delta Apparel, Inc. (DLA)

Delta Apparel, Inc. (NYSE MKT: DLA) is an international design, marketing, manufacturing and sourcing company with a broad portfolio of lifestyle-branded active wear apparel and headwear; the company also produces high-quality private label programs. Delta Apparel’s operating subsidiaries include M.J. Soffe LLC, Junkfood Clothing Company, To The Game LLC and Art Gun LLC. Delta Apparel specializes in selling casual and athletic products across distribution tiers and in most types of stores. For more information, visit the company’s Web site:

Dendreon Corp. (DNDN)

Dendreon Corp. (NASDAQ: DNDN) is a biotechnology company focused on targeting cancer and transforming lives through discovering, developing, commercializing and manufacturing novel therapeutics. Dendreon utilizes its antigen identification, engineering and cell processing expertise to produce active cellular immunotherapy (ACI) product candidates that are designed to stimulate an immune response in various tumor types. PROVENGE (sipuleucel-T), the company’s first product, received FDA approval in April 2010. For more information, visit the company’s Web site:

Denison Mines Corp. (DNN)

Denison Mines Corp. (NYSE MKT: DNN) is a uranium exploration and development company focused on exploration and development projects in Saskatchewan, Zambia and Mongolia. The company’s exploration project portfolio consists of 26 projects totaling over 330,000 hectares in the Eastern Athabasca Basin region of Saskatchewan, including the world-class Phoenix deposits on its 60% owned Wheeler River project. The company has partial ownership interest in various other locations and owns 100% of the conventional heap leach Mutanga project in Zambia. For more information, visit the company’s Web site:

Depomed, Inc. (DEPO)

Depomed, Inc. (NASDAQ: DEPO) is a specialty pharmaceutical company that formulates its products and product candidates with its proprietary Acuform drug delivery technology – designed to improve existing oral medications, allowing for extended release of medications to the upper gastrointestinal tract when dosed with food. The company currently has three approved and marketed products: Gralise, a treatment for postherpetic neuralgia; Zipsor, an NSAID indicated for mild to moderate acute pain relief in adults; and Glumetza for adults with type 2 diabetes. For more information, visit the company’s Web site:

Derma Sciences, Inc. (DSCI)

Derma Sciences, Inc. (NASDAQ: DSCI) is a medical technology company with its focus on advanced wound care. The company currently targets three segments of the wound care marketplace: pharmaceutical wound care products; advanced wound care dressings addressing chronic wounds, including diabetic ulcers; and traditional dressings. Based on excellent Phase 2 data, the company has commenced Phase 3 clinical trials in diabetic foot ulcer healing with DSC127. Other novel products include the company’s MEDIHONEY product, TCC-EZ, XTRASORB and BIOGUARD. For more information, visit the company’s Web site:

Destination Maternity Corp. (DEST)

Destination Maternity Corp. (NASDAQ: DEST) is a leading global designer and retailer of maternity apparel. As of Dec. 31, 2012, the company operated 1,887 retail locations – including 621 stores – in the U.S. and Canada, as well as 1,266 leased department locations. The company additionally sells its products online through its and brand-specific Web sites, distributes products through a licensed arrangement with Kohl’s and is expanding internationally. For more information, visit the company’s Web site:

DexCom, Inc. (DXCM)

DexCom, Inc. (NASDAQ: DXCM) is a leading provider of glucose sensing technologies, focused on developing and marketing continuous glucose monitoring systems for ambulatory use by patients and healthcare providers in hospital settings. Founded in 1999, the company began with a focus on creating an implantable glucose sensor that would perform for an extended period of time without being rejected by the body. For more information, visit the company’s Web site:

DFC Global Corp. (DLLR)

DFC Global Corp. (NASDAQ: DLLR) is an international diversified financial services company chiefly serving unbanked and under-banked consumers. In business for over 30 years, DFC Global operates through more than 1,400 retail storefront locations, multiple Internet Web sites, and mobile phone and other remote platforms to provide a variety of consumer financial products and services in nine countries across North America and Europe. For more information visit the company's Web site:

DG, Inc. (DGIT)

DG, Inc. (NASDAQ: DGIT) is a global leader in ad management and distribution, connecting more than 11,000 worldwide advertisers and agencies with their targeted audiences through an extensive network of more than 6,000 TV broadcast stations and more than 11,500 Web publishers. DG’s television segment enables advertisers and agencies to work faster, smarter and more competitively, and the company’s online segment provides marketers with optimized management of online advertising campaigns, enabling them to maximize data-driven advertising. For more information, visit the company’s Web site:

DHX Media Ltd. (DHX)

DHX Media Ltd. (TSX: DHX) is a leading independent creator, producer and licensor of family entertainment rights – owning, marketing and distributing more than 8,500 half-hours of children’s entertainment content and exploiting owned properties through its consumer products licensing business. The company is noted for brands like “Caillou,” “Busytown Mysteries,” “Inspector Gadget,” “Johnny Test,” “Animal Mechanicals,” “Kid vs. Kat,” “Super WHY!,” “Rastamouse” and “Yo Gabba Gabba!” DHX Media also provides programming for the CBS weekend morning block “Cookie Jar TV.” For more information, visit the company’s Web site:

Discovery Laboratories, Inc. (DSCO)

Discovery Laboratories, Inc. (NASDAQ: DSCO) is a specialty biotechnology company engaged in the advancement of a new standard in respiratory critical care. The company’s novel proprietary KL4 surfactant technology creates a synthetic, peptide-containing surfactant that is similar in structure to pulmonary surfactant, and Discovery Labs is also developing its proprietary drug delivery technologies to facilitate efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. For more information, visit the company’s Web site:

Dorel Industries, Inc. (DII)

Dorel Industries, Inc. (DII-A.TO) engages in designing, manufacturing or sourcing, marketing, and distributing various consumer products worldwide. The company operates in three segments: Juvenile, Recreational/Leisure, and Home Furnishings. Dorel sells its products primarily to mass merchant discount chains, specialty stores, department stores, hardware/home centers, independent stores, sporting goods stores and Internet retailers. It owns and operates approximately 52 baby Infanti stores comprising 40 stores in Chile and 12 in Peru. For more information, visit the company's Web site at:

Dot Hill Systems Corp. (HILL)

Dot Hill Systems Corp. (NASDAQ: HILL) is a leading provider of SAN storage solutions. The company delivers innovative technology and global support, empowering the OEM and channels community to bring storage solutions to market quickly, easily and cost-effectively. Dot Hill’s RAID technology offers high performance and industry-leading uptime and is the foundation for best-in-class storage solutions. The company’s solutions are certified to meet meticulous industry standards and military specifications, as well as RoHS and WEEE international environmental standards. For more information, visit the company’s Web site:

Dyax Corp. (DYAX)

Dyax Corp. (NASDAQ: DYAX) is a fully integrated biopharmaceutical company engaged in discovering, developing and commercializing novel biotherapeutics for unmet medical needs. The KALBITOR (ecallantide) business, the angioedema portfolio and the Licensing and Funded Research Program (LFRP) are the company’s key value drivers. KALBITOR was developed independently by Dyax, and the company has been selling this product in the U.S. since 2010 as a treatment for acute attack of hereditary angioedema in patients 16 and older. For more information, visit the company’s Web site:

ECOtality, Inc. (ECTY)

ECOtality, Inc. (NASDAQ: ECTY) is a leading provider of clean electric transportation and storage technologies, with a focus on developing and commercializing environmentally friendly energy systems and solutions to address today’s global energy challenge. Through its innovation, acquisitions and strategic partnerships, ECOtality is engaged in accelerating the market applicability of advanced electric technologies as a replacement for carbon-based fuels. The company’s headquarters are located in San Francisco, Calif. For more information, visit the company’s Web site:

Edgewater Technology, Inc. (EDGW)

Edgewater Technology, Inc. (NASDAQ: EDGW) is a leading strategic consulting firm that delivers a combination of classic consulting and product-based consulting services. The company addresses the market both vertically by industry and horizontally by product and technology specialty, giving its clients a broad range of business and technology solutions. One of the largest IT consulting firms based in New England, Edgewater works with clients to reduce costs, improve processes and grow revenue through the judicious use of technology. For more information, visit the company’s Web site:

eGain Communication Corp. (EGAN)

eGain Communication Corp. (NASDAQ: EGAN) leads the industry in providing cloud customer engagement solutions. eGain’s solutions are trusted by leading brands and aid in the design and delivery of smart, connected customer journeys across social, mobile, Web and contact centers. The company’s headquarters are located in Sunnyvale, Calif., and eGain has operating presence in North America, EMEA and APAC. For more information, visit the company’s Web site:

Electro Scientific Industries, Inc. (ESIO)

Electro Scientific Industries, Inc. (NASDAQ: ESIO) is a leader in supplying advanced laser-based manufacturing solutions for the microtechnology industry. ESI’s systems facilitate precision structuring and testing of micron to submicron features in semiconductors, electronic devices, LEDs and other high-value components. The company partners with customers to create innovative technology breakthroughs in burgeoning industries such as the semiconductor and microelectronics industries. ESI is based in Portland, Ore., with worldwide operations from the Pacific Rim to the Pacific Northwest. For more information, visit the company’s Web site:


EMCORE Corp. (NASDAQ: EMKR) is a leader in providing compound semiconductor-based components and subsystems for the fiber optics and solar power markets. The company’s Fiber Optics business segment offers optical components, subsystems and systems for high-speed telecommunications, cable television and FTTP networks, as well as products for satellite communications, video transport and specialty photonics technologies for defense and homeland security applications. EMCORE’s Solar Photovoltaics business segment provides products for space power applications. For more information, visit the company’s Web site:

Endocyte, Inc. (ECYT)

Endocyte, Inc. (NASDAQ: ECYT) is a biopharmaceutical company engaged in the development of targeted therapies to treat cancer and inflammatory diseases. The company utilizes its proprietary technology in creating novel SMDCs and companion imaging diagnostics for personalized targeted therapies. Endocyte’s SMDCs actively target receptors that are overexpressed on diseased cells relative to healthy cells – facilitating patient treatment with highly active drugs at greater doses, delivered more frequently and over longer periods than with the untargeted drug alone. For more information, visit the company’s Web site:

Endologix, Inc. (ELGX)

Endologix, Inc. (NASDAQ: ELGX) is a developer and manufacturer of minimally invasive aortic disorder treatments. The company’s focus is on endovascular stent grafts for treating abdominal aortic aneurysms (AAA), which are a weakening of the wall of the aorta – the body’s largest artery – resulting in a balloon-like enlargement. AAA continues to enlarge once it has developed, and it becomes increasingly susceptible to rupture if left untreated. Ruptured AAA is a leading cause of death in the United States. For more information, visit the company’s Web site:

Energy Fuels, Inc. (EFR)

Energy Fuels, Inc. (TSX: EFR) is the largest conventional uranium producer in America. The company supplies around 25% of the uranium produced in the United States and is also a significant vanadium producer. Energy Fuels operates the White Mesa Mill – the only conventional uranium mill currently operational within the U.S., with a processing capacity of 2,000 tons of uranium ore per day – as well as other mines and mineral properties throughout the Western U.S. For more information, visit the company’s Web site:

Energy Recovery, Inc. (ERII)

Energy Recovery, Inc. (NASDAQ: ERII) is a global leader in harnessing energy from industrial fluid flows and pressure cycles. Industrial processes within the water, oil and gas, and chemical industries have been made environmentally cleaner and more economically profitable through the company’s innovations. Energy Recovery’s high-efficiency technologies deliver substantial cost savings and provide the best economics for any industrial application. With installations on every continent, the company saves its clients more than $1 billion in annual energy costs. For more information, visit the company’s Web site:

EnteroMedics, Inc. (ETRM)

EnteroMedics, Inc. (NASDAQ: ETRM) is a medical device company engaged in developing and commercializing its neuroscience-based technology for treating obesity and metabolic diseases. VBLOC vagal blocking therapy, the company’s proprietary technology, is delivered by a pacemaker-like device called the Maestro Rechargeable System and is designed to intermittently block the vagus nerves using high-frequency, low-energy electrical impulses. VBLOC enables people with obesity to take positive steps toward weight loss. For more information, visit the company’s Web site:

Entertainment Gaming Asia, Inc. (EGT)

Entertainment Gaming Asia, Inc. (NASDAQ: EGT), a leading gaming company in Pan-Asia, is engaged in developing and operating casinos and gaming venues in the Indo-China region under its “Dreamworld” brand, as well as leasing electronic gaming machines to the gaming industry on a revenue-sharing basis. Under its “Dolphin” brand, the company manufactures and sells RFID and traditional gaming chips and plaques to major casinos. For more information, visit the company’s Web site:

Entropic Communications, Inc. (ENTRI)

Entropic Communications, Inc. (NASDAQ: ENTRI) is a global leader in providing semiconductor solutions for the connected home – transforming the way traditional HDTV broadcast and IP-based streaming video content are seamlessly, reliably and securely delivered, processed and distributed into and throughout the home. Entropic's pioneering home connectivity and set-top box system-on-a-chip (SoC) solutions enable Pay-TV service providers to give their consumers a more captivating whole-home entertainment experience by delivering new, high-performance ways to connect, engage and enjoy digital entertainment. For more information, visit the company’s Web site:

Erickson Air-Crane, Inc. (EAC)

Erickson Air-Crane, Inc. (NASDAQ: EAC) operates and manufactures the Erickson S-64, a powerful multipurpose heavy-lift helicopter. With a lift capacity of up to 25,000 pounds, the Aircrane is the only commercial aircraft that has been built specifically as a flying crane without a fuselage for internal loads, and the only heavy-lift helicopter with a rear load-facing cockpit. The company owns and operates a fleet of 18 Aircranes, used by a broad range of government and commercial customers worldwide. For more information, visit the company’s Web site:

Esperanza Resources Corp. (EPZ)

Esperanza Resources Corp. (TSX-V: EPZ) is a precious metals exploration and development company engaged in advancing the Esperanza gold project, its wholly owned principal property in Morelos State, Mexico, and bringing it into production. The Esperanza gold project is a low-cost, open pit heap leach operation anticipated to produce strong cash flow, which will be used to grow the company through the expansion of its portfolio of precious metal projects. For more information, visit the company’s Web site:

Exact Sciences Corp. (EXAS)

Exact Sciences Corp. (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Science's portfolio includes exclusive intellectual property protecting its noninvasive molecular screening technology for the detection of colorectal cancer. The company engages in stool-based DNA (sDNA) technology, which is included in the cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, visit the company's Web site:

Exar Corporation (EXAR)

Exar Corporation (NASDAQ: EXAR) is a leading designer, developer and marketer of high performance, analog mixed-signal integrated circuits and advanced sub-system solutions. The company’s product portfolio includes power management and connectivity components, communications products and network security and storage optimization solutions. The company provides real-time customer support through its locations across the globe. For more information, visit the company’s Web site:

EZchip Semiconductor Ltd. (EZCH)

EZchip Semiconductor Ltd. (NASDAQ: EZCH) is a leading fabless semiconductor company providing Ethernet network processors for networking equipment. The company’s solutions scale from a few to hundreds of gigabits-per-second, and its network processors provide tremendous flexibility and high performance, combined with superior integration and power efficiency, for a broad range of applications in carrier, cloud and data center network equipment. For more information, visit the company’s Web site:


For more frequent updates, follow us on Twitter!

Home     About Us     Blog     Investors     IR Services     Market Research     Partners     Contact     Disclaimer

© 2012 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975